| Year |
Citation |
Score |
| 2021 |
Pearce ME, Jongbloed K, Pooyak S, Christian WM, Teegee MGWWM, Caron NR, Thomas V, Henderson E, Zamar D, Yoshida EM, Schechter MT, Spittal PM. The Cedar Project: exploring the role of colonial harms and childhood maltreatment on HIV and hepatitis C infection in a cohort study involving young Indigenous people who use drugs in two Canadian cities. Bmj Open. 11: e042545. PMID 34244246 DOI: 10.1136/bmjopen-2020-042545 |
0.303 |
|
| 2011 |
Chertov O, Zhang N, Chen X, Oppenheim JJ, Lubkowski J, McGrath C, Sowder RC, Crise BJ, Malyguine A, Kutzler MA, Steele AD, Henderson EE, Rogers TJ. Novel peptides based on HIV-1 gp120 sequence with homology to chemokines inhibit HIV infection in cell culture. Plos One. 6: e14474. PMID 21264298 DOI: 10.1371/Journal.Pone.0014474 |
0.528 |
|
| 2010 |
WASNER M, HENDERSON EE, SUHADOLNIK RJ, PFLEIDERER W. ChemInform Abstract: Nucleotides. Part 44. Synthesis, Characterization, and Biological Activity of Monomeric and Trimeric Cordycepin-Cholesterol Conjugates and Inhibition of HIV-1 Replication Cheminform. 26: no-no. DOI: 10.1002/chin.199514287 |
0.436 |
|
| 2008 |
Smirnova EV, Collingwood TS, Bisbal C, Tsygankova OM, Bogush M, Meinkoth JL, Henderson EE, Annan RS, Tsygankov AY. TULA proteins bind to ABCE-1, a host factor of HIV-1 assembly, and inhibit HIV-1 biogenesis in a UBA-dependent fashion. Virology. 372: 10-23. PMID 18006034 DOI: 10.1016/J.Virol.2007.10.012 |
0.56 |
|
| 2007 |
Raymond AD, Hasham M, Tsygankov AY, Henderson EE. Herpesvirus saimiri terminal membrane proteins modulate HIV-1 replication by altering Nef and Tat functions. Current Hiv Research. 5: 79-86. PMID 17266559 DOI: 10.2174/157016207779316314 |
0.774 |
|
| 2007 |
Dimitrova DI, Reichenbach NL, Yang X, Pfleiderer W, Charubala R, Gaughan JP, Suh B, Henderson EE, Suhadolnik RJ, Rogers TJ. Inhibition of HIV type 1 replication in CD4+ and CD14 + cells purified from HIV type 1-infected individuals by the 2-5A agonist immunomodulator, 2-5AN6B Aids Research and Human Retroviruses. 23: 123-134. PMID 17263642 DOI: 10.1089/Aid.2005.0091 |
0.482 |
|
| 2006 |
Turner LS, Tsygankov AY, Henderson EE. StpC-based gene therapy targeting latent reservoirs of HIV-1. Antiviral Research. 72: 233-41. PMID 16891001 DOI: 10.1016/J.Antiviral.2006.06.010 |
0.769 |
|
| 2006 |
Raymond AD, Hasham M, Tsygankov AY, Henderson EE. H. saimiri tyrosine-kinase interacting protein inhibits Tat function: a prototypic strategy for restricting HIV-1-induced cytopathic effects in immune cells. Virology. 352: 253-67. PMID 16780912 DOI: 10.1016/J.Virol.2006.04.016 |
0.778 |
|
| 2005 |
Dimitrova DI, Yang X, Reichenbach NL, Karakasidis S, Sutton RE, Henderson EE, Rogers TJ, Suhadolnik RJ. Lentivirus-mediated transduction of PKR into CD34(+) hematopoietic stem cells inhibits HIV-1 replication in differentiated T cell progeny. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 25: 345-60. PMID 15957958 DOI: 10.1089/Jir.2005.25.345 |
0.585 |
|
| 2004 |
Raymond AD, Hasham MG, Tsygankov AY, Henderson EE. Herpesvirus saimiri-encoded proteins Tip and StpC modulate human immunodeficiency virus type 1 replication in T-cell lines and lymphocytes independently of viral tropism. Virology. 324: 60-6. PMID 15183053 DOI: 10.1016/J.Virol.2004.03.021 |
0.761 |
|
| 2003 |
Szabo I, Wetzel MA, Zhang N, Steele AD, Kaminsky DE, Chen C, Liu-Chen LY, Bednar F, Henderson EE, Howard OM, Oppenheim JJ, Rogers TJ. Selective inactivation of CCR5 and decreased infectivity of R5 HIV-1 strains mediated by opioid-induced heterologous desensitization. Journal of Leukocyte Biology. 74: 1074-82. PMID 12972507 DOI: 10.1189/Jlb.0203067 |
0.743 |
|
| 2003 |
Steele AD, Henderson EE, Rogers TJ. Mu-opioid modulation of HIV-1 coreceptor expression and HIV-1 replication. Virology. 309: 99-107. PMID 12726730 DOI: 10.1016/S0042-6822(03)00015-1 |
0.558 |
|
| 2002 |
Homan JW, Steele AD, Martinand-Mari C, Rogers TJ, Henderson EE, Charubala R, Pfleiderer W, Reichenbach NL, Suhadolnik RJ. Inhibition of morphine-potentiated HIV-1 replication in peripheral blood mononuclear cells with the nuclease-resistant 2-5A agonist analog, 2-5A(N6B). Journal of Acquired Immune Deficiency Syndromes (1999). 30: 9-20. PMID 12048358 DOI: 10.1097/00042560-200205010-00002 |
0.537 |
|
| 2002 |
Wetzel MA, Steele AD, Henderson EE, Rogers TJ. The effect of X4 and R5 HIV-1 on C, C-C, and C-X-C chemokines during the early stages of infection in human PBMCs. Virology. 292: 6-15. PMID 11878903 DOI: 10.1006/Viro.2001.1249 |
0.56 |
|
| 2002 |
Charubala R, Pfleiderer W, Suhadolnik RJ, Iacono KT, Muto NF, Homan JW, Martinand-Mari C, Horvath SE, Henderson EE, Steele A, Rogers TJ. Nucleotides: Part LXX. Inhibition of HIV-1 replication by chemically synthesized, nuclease-resistant, nontoxic (2′→5′)-oligoadenylate agonists Helvetica Chimica Acta. 85: 2284-2299. DOI: 10.1002/1522-2675(200208)85:8<2284::Aid-Hlca2284>3.0.Co;2-E |
0.341 |
|
| 2001 |
Le Y, Wetzel MA, Shen W, Gong W, Rogers TJ, Henderson EE, Wang JM. Desensitization of chemokine receptor CCR5 in dendritic cells at the early stage of differentiation by activation of formyl peptide receptors. Clinical Immunology (Orlando, Fla.). 99: 365-72. PMID 11358433 DOI: 10.1006/Clim.2001.5021 |
0.373 |
|
| 2001 |
Li BQ, Wetzel MA, Mikovits JA, Henderson EE, Rogers TJ, Gong W, Le Y, Ruscetti FW, Wang JM. The synthetic peptide WKYMVm attenuates the function of the chemokine receptors CCR5 and CXCR4 through activation of formyl peptide receptor-like 1. Blood. 97: 2941-7. PMID 11342415 DOI: 10.1182/Blood.V97.10.2941 |
0.523 |
|
| 2000 |
Wetzel MA, Steele AD, Eisenstein TK, Adler MW, Henderson EE, Rogers TJ. Mu-opioid induction of monocyte chemoattractant protein-1, RANTES, and IFN-gamma-inducible protein-10 expression in human peripheral blood mononuclear cells. Journal of Immunology (Baltimore, Md. : 1950). 165: 6519-24. PMID 11086093 DOI: 10.4049/Jimmunol.165.11.6519 |
0.542 |
|
| 2000 |
Shen W, Li B, Wetzel MA, Rogers TJ, Henderson EE, Su SB, Gong W, Le Y, Sargeant R, Dimitrov DS, Oppenheim JJ, Wang JM. Down-regulation of the chemokine receptor CCR5 by activation of chemotactic formyl peptide receptor in human monocytes Blood. 96: 2887-2894. DOI: 10.1182/blood.V96.8.2887.h8002887_2887_2894 |
0.346 |
|
| 1999 |
Henderson EE, Tsygankov AY, Merlo JJ, Romano G, Guan M. Altered replication of human immunodeficiency virus type 1 (HIV-1) in T cell lines retrovirally transduced to express Herpesvirus saimiri proteins StpC and/or Tip. Virology. 264: 125-33. PMID 10544137 DOI: 10.1006/Viro.1999.9988 |
0.61 |
|
| 1999 |
Kvasyuk EI, Mikhailopulo IA, Suhadolnik RJ, Henderson EE, Muto NF, Iacono KT, Homon J, Pfleiderer W. Synthesis and biological activity of 2',5'-oligoadenylate trimers containing 5'-terminal 5'-amino-5'-deoxy-and 5'-amino-3',5'-dideoxyadenosine derivatives Nucleosides and Nucleotides. 18: 1483-1484. PMID 10474228 DOI: 10.1080/07328319908044760 |
0.513 |
|
| 1998 |
Garriga J, Peng J, Parreño M, Price DH, Henderson EE, Graña X. Upregulation of cyclin T1/CDK9 complexes during T cell activation Oncogene. 17: 3093-3102. PMID 9872325 DOI: 10.1038/Sj.Onc.1202548 |
0.442 |
|
| 1998 |
Salgame P, Guan MX, Agahtehrani A, Henderson EE. Infection of T cell subsets by HIV-1 and the effects of interleukin-12 Journal of Interferon and Cytokine Research. 18: 521-528. PMID 9712368 DOI: 10.1089/Jir.1998.18.521 |
0.513 |
|
| 1998 |
Kvasyuk EI, Kulak TI, Tkachenko OV, Sentyureva SL, Mikhailopulo IA, Suhadolnik RJ, Henderson EE, Horvath SE, Guan M, Pfleiderer W. Nucleotides. Part LVI. Synthesis and biological activity of modified (2?-5?)triadenylates containing 2?-terminal 2?,3?-dideoxy-3?-fluoroadenosine derivatives Helvetica Chimica Acta. 81: 1278-1284. DOI: 10.1002/Hlca.19980810538 |
0.472 |
|
| 1997 |
Romano G, Guan M, Long WK, Henderson EE. Differential effects on HIV-1 gene regulation by EBV in T lymphocytic and promonocytic cells transduced to express recombinant human CR2 (CD21) Virology. 237: 23-32. PMID 9344904 DOI: 10.1006/Viro.1997.8764 |
0.605 |
|
| 1997 |
Guan M, Tudor G, Yang JY, Henderson EE. Structure and origin of HIV type 1 DNA in persistently infected B lymphoblastoid cell lines Aids Research and Human Retroviruses. 13: 751-758. PMID 9171219 DOI: 10.1089/Aid.1997.13.751 |
0.604 |
|
| 1997 |
Zhang RD, Guan M, Park Y, Tawadros R, Yang JY, Gold B, Wu B, Henderson EE. Synergy between human immunodeficiency virus type 1 and Epstein-Barr virus in T lymphoblastoid cell lines Aids Research and Human Retroviruses. 13: 161-172. PMID 9007201 DOI: 10.1089/Aid.1997.13.161 |
0.568 |
|
| 1997 |
Kvasyuk EI, Kulak TI, Mikhailopulo IA, Suhadolnik RJ, Henderson EE, Horvath SE, Guan M, Pfleiderer W. Synthesis and Biological Activity of New 2′ 5′-Oligonucleotides Nucleosides and Nucleotides. 16: 1351-1354. DOI: 10.1080/07328319708006186 |
0.52 |
|
| 1997 |
Kvasyuk EI, Kulak TI, Tkachenko OV, Sentyureva SL, Mikhailopulo IA, Suhadolnik RJ, Henderson EE, Horvath SE, Gun MX, Pfleiderer W. Synthesis and Biological Activity of New Sugar Modified 2′,5′-Oligoadenylate Trimers Nucleosides and Nucleotides. 16: 773-776. DOI: 10.1080/07328319708002949 |
0.488 |
|
| 1997 |
Wasner M, Suhadolnik RJ, Horvath SE, Adelson ME, Kon N, Guan X, Henderson EE, Pfleiderer W. Nucleotides: LIII. 6-aminohexanoyl-linked conjugates of monomeric and trimeric cordycepin Helvetica Chimica Acta. 80: 1061-1072. DOI: 10.1002/Hlca.19970800405 |
0.379 |
|
| 1997 |
Kvasyuk EI, Kulak TI, Tkachenko OV, Sentyureva SL, Mikhailopulo IA, Suhadolnik RJ, Horvath SE, Henderson EE, Guan M, Pfleiderer W. Nucleotides. Part LII. Synthesis and biological activity of new base-modified (2?-5?)oligoadenylate trimers Helvetica Chimica Acta. 80: 1053-1060. DOI: 10.1002/Hlca.19970800404 |
0.529 |
|
| 1996 |
Guan M, Zhang RD, Wu B, Henderson EE. Infection of primary CD4+ and CD8+ T lymphocytes by Epstein-Barr virus enhances human immunodeficiency virus expression Journal of Virology. 70: 7341-7346. PMID 8794395 DOI: 10.1128/jvi.70.10.7341-7346.1996 |
0.401 |
|
| 1996 |
Wasner M, Pfleiderer W, Suhadolnik RJ, Horvath SE, Kon N, Guan M, Henderson EE, Adelson ME. Nucleotides. Part IL. Synthesis and Characterization of Cordycepin‐Trimer‐Vitamin and ‐Lipid Conjugates Potential Inhibitors of HIV‐1 Replication Helvetica Chimica Acta. 79: 619-633. DOI: 10.1002/Hlca.19960790305 |
0.546 |
|
| 1996 |
Wasner M, Suhadolnik RJ, Horvath SE, Adelson ME, Kon N, Guan MX, Henderson EE, Pfleiderer W. Synthesis and characterization of monomeric cordycepin-vitamin and cordycepin-lipid conjugates model substances for biodegradable ester and carbonate linkages in conjugates and potential inhibitors of HIV-1 replication Helvetica Chimica Acta. 79: 609-618. DOI: 10.1002/Hlca.19960790304 |
0.47 |
|
| 1996 |
Wasner M, Sahadolnik RJ, Horvath SE, Adelson ME, Kon N, Guan MX, Henderson EE, Pfleiderer W. Nucleotides Part IL: Synthesis and characterization of cordycepin-trimer-vitamin and -lipid conjugates potential inhibitors of HIV-1 replication Helvetica Chimica Acta. 79: 619-633. |
0.335 |
|
| 1995 |
Sobol RW, Henderson EE, Kon N, Shao J, Hitzges P, Mordechai E, Reichenbach NL, Charubala R, Schirmeister H, Pfleiderer W. Inhibition of HIV-1 replication and activation of RNase L by phosphorothioate/phosphodiester 2',5'-oligoadenylate derivatives. The Journal of Biological Chemistry. 270: 5963-78. PMID 7890727 DOI: 10.1074/Jbc.270.11.5963 |
0.529 |
|
| 1995 |
Mordechai E, Kon N, Henderson EE, Suhadolnik RJ. Activation of the Interferon-lnducible Enzymes, 2′, 5′-Oligoadenylate Synthetase and PKR by Human T-Cell Leukemia Virus Type I Rex-Response Element Virology. 206: 913-922. PMID 7856104 DOI: 10.1006/Viro.1995.1014 |
0.359 |
|
| 1994 |
Yang JY, Schwartz A, Henderson EE. Inhibition of 3'azido-3'deoxythymidine-resistant HIV-1 infection by dehydroepiandrosterone in vitro Biochemical and Biophysical Research Communications. 201: 1424-1432. PMID 8024587 DOI: 10.1006/Bbrc.1994.1862 |
0.585 |
|
| 1994 |
Zhang RD, Henderson EE. CD4 mRNA expression in CD19-positive B cells and its suppression by the Epstein-Barr virus Virology. 198: 709-713. PMID 7507284 DOI: 10.1006/Viro.1994.1083 |
0.444 |
|
| 1994 |
Wasner M, Henderson EE, Suhadolnik RJ, Pfleiderer W. Nucleotides. Part XLIV. Synthesis, characterization, and biological activity of monomeric and trimeric cordycepin-cholesterol conjugates and inhibition of HIV-1 replication Helvetica Chimica Acta. 77: 1757-1767. DOI: 10.1002/Hlca.19940770707 |
0.433 |
|
| 1993 |
Yang JY, Schwartz A, Henderson EE. Inhibition of HIV-1 latency reactivation by dehydroepiandrosterone (DHEA) and an analog of DHEA Aids Research and Human Retroviruses. 9: 747-754. PMID 7692906 DOI: 10.1089/Aid.1993.9.747 |
0.609 |
|
| 1992 |
Henderson E, Yang JY, Schwartz A. Dehydroepiandrosterone (DHEA) and synthetic DHEA analogs are modest inhibitors of HIV-1 IIIB replication. Aids Research and Human Retroviruses. 8: 625-31. PMID 1381206 DOI: 10.1089/Aid.1992.8.625 |
0.584 |
|
| 1992 |
Henderson EE, Tudor G, Yang J. Inactivation of the Human Immunodeficiency Virus Type 1 (HIV-1) by Ultraviolet and X Irradiation Radiation Research. 131: 169. DOI: 10.2307/3578438 |
0.563 |
|
| 1991 |
Kusewitt DF, Ley RD, Henderson EE. Enhanced pyrimidine dimer removal in repair-proficient murine fibroblasts transforme with the denV gene of bacteriophage T4 Mutation Research-Dna Repair. 255: 1-9. PMID 2067547 DOI: 10.1016/0921-8777(91)90012-E |
0.305 |
|
| 1991 |
Henderson EE, Yang JY, Zhang RD, Bealer M. Altered HIV expression and EBV-induced transformation in coinfected PBLs and PBL subpopulations Virology. 182: 186-198. PMID 1708929 DOI: 10.1016/0042-6822(91)90662-U |
0.62 |
|
| 1990 |
Seal G, Henderson EE, Sirover MA. Immunological alteration of the Bloom's syndrome uracil DNA glycosylase in Epstein-Barr virus-transformed human lymphoblastoid cells Mutation Research Letters. 243: 241-248. PMID 2155388 DOI: 10.1016/0165-7992(90)90097-4 |
0.328 |
|
| 1989 |
Henderson EE, Valerie K, Green AP, de Riel JK. Host cell reactivation of CAT-expression vectors as a method to assay for cloned DNA-repair genes Mutation Research/Reviews in Genetic Toxicology. 220: 151-160. PMID 2927423 DOI: 10.1016/0165-1110(89)90021-3 |
0.355 |
|
| 1989 |
Fronko GE, Long WK, Wu B, Papadopoulos T, Henderson EE. Relationship between methylation status and expression of an epstein-barr virus (EBV) capsid antigen gene Biochemical and Biophysical Research Communications. 159: 263-270. PMID 2538121 DOI: 10.1016/0006-291X(89)92432-7 |
0.325 |
|
| 1989 |
Henderson EE, Franks C, Fronko G. Chemical carcinogen Epstein-Barr virus (EBV) synergism: EBV genome amplification and site-specific mutation during transformation International Journal of Cancer. 43: 72-79. PMID 2536010 DOI: 10.1002/Ijc.2910430116 |
0.326 |
|
| 1988 |
Fronko GE, Suhadolnik RJ, Vonderheid EC, Karikó K, Reichenbach NL, Chavin KD, Henderson EE. Decreased Epstein-Barr virus-induced transformation, and elevated 2-5A synthetase and RNase L activity in peripheral blood mononuclear cells from patients treated with recombinant interferon alfa 2b Biochemical and Biophysical Research Communications. 153: 448-453. PMID 2837212 DOI: 10.1016/S0006-291X(88)81245-2 |
0.336 |
|
| 1986 |
Valerie K, Fronko G, Henderson EE, de Riel JK. Expression of the denV gene of coliphage T4 in UV-sensitive rad mutants of Saccharomyces cerevisiae Molecular and Cellular Biology. 6: 3559-3562. PMID 3540595 DOI: 10.1128/Mcb.6.10.3559 |
0.325 |
|
| 1986 |
Valerie K, de Riel JK, Henderson EE. Restoration of DNA repair in UV-sensitive Chinese hamster ovary cell by the denV gene from bacteriophage T4 Basic Life Sciences. 38: 319-326. PMID 3017288 DOI: 10.1007/978-1-4615-9462-8_34 |
0.314 |
|
| 1985 |
Stavnezer J, Kekish O, Batter D, Grenier J, Balazs I, Henderson E, Zegers BJ. Aberrant recombination events in B cell lines derived from a kappa-deficient human. Nucleic Acids Research. 13: 3495-3514. PMID 3925437 DOI: 10.1093/Nar/13.10.3495 |
0.301 |
|
| 1985 |
Valerie K, De Riel JK, Henderson EE. Genetic complementation of UV-induced DNA repair in Chinese hamster ovary cells by the denV gene of phage T4 Proceedings of the National Academy of Sciences of the United States of America. 82: 7656-7660. PMID 3865186 DOI: 10.1073/Pnas.82.22.7656 |
0.315 |
|
| 1985 |
Babilon RW, Soprano KJ, Henderson EE. Hypersensitivity and reduced inhibition of DNA synthesis in ataxia telangiectasia lymphoblasts treated with low levels of neocarzinostatin Mutation Research Dna Repair Reports. 146: 79-87. PMID 3158810 DOI: 10.1016/0167-8817(85)90058-6 |
0.339 |
|
| 1985 |
Valerie K, Henderson EE, De Riel JK. Expression of a cloned denV gene of bacteriophage T4 in Escherichia coli Proceedings of the National Academy of Sciences of the United States of America. 82: 4763-4767. PMID 2991891 DOI: 10.1073/Pnas.82.14.4763 |
0.31 |
|
| 1984 |
Henderson EE, Fronko G. Studies on chemical carcinogen enhancement of Epstein-Barr virus induced transformation of human neonatal and adult peripheral blood lymphocytes International Journal of Cancer. 33: 331-338. PMID 6321362 DOI: 10.1002/Ijc.2910330309 |
0.38 |
|
| 1983 |
Henderson EE, Basilio M. Transformation and Repair Replication in Lymphocytes from Ataxia Telangiectasia1 Proceedings of the Society For Experimental Biology and Medicine. 172: 524-534. PMID 6302713 DOI: 10.3181/00379727-172-41598 |
0.367 |
|
| 1982 |
Henderson EE, Doetsch PW, Charubala R, Pfleiderer W, Suhadolnik RJ. Inhibition of Epstein-Barr virus-associated nuclear antigen (EBNA) induction by (2',5')oligoadenylate and the cordycepin analog: mechanism of action for inhibition of EBV-induced transformation. Virology. 122: 198-201. PMID 6291233 DOI: 10.1016/0042-6822(82)90389-0 |
0.363 |
|
| 1981 |
Henderson EE, Long WK. Host cell reactivation of uv- and X-ray-damaged herpes simplex virus by epstein-barr virus (EBV)-transformed lymphoblastoid cell lines Virology. 115: 237-248. PMID 6274084 DOI: 10.1016/0042-6822(81)90107-0 |
0.378 |
|
| 1981 |
Henderson E, Schwartz A, Pashko L, Abou-Gharbia M, Swern D. Dehydroepiandrosterone and 16α-bromo-epiandrosterone: inhibitors of Epstein-Barr virus-induced transformation of human lymphocytes Carcinogenesis. 2: 683-686. PMID 6268330 DOI: 10.1093/Carcin/2.7.683 |
0.329 |
|
| 1981 |
Levitt M, Shungu D, Henderson E. Colony morphology, cell growth and viral radiosensitivity as parameters for detecting strain differences in Epstein-Barr virus (EBV). International Journal of Cancer. 26: 509-15. PMID 6265384 DOI: 10.1002/Ijc.2910260417 |
0.347 |
|
| 1981 |
Doetsch PW, Suhadolnik RJ, Sawada Y, Mosca JD, Flick MB, Reichenbach NL, Dang AQ, Wu JM, Charubala R, Pfleiderer W, Henderson EE. Core (2'-5')oligoadenylate and the cordycepin analog: inhibitors of Epstein--Barr virus-induced transformation of human lymphocytes in the absence of interferon. Proceedings of the National Academy of Sciences of the United States of America. 78: 6699-703. PMID 6171822 DOI: 10.1073/Pnas.78.11.6699 |
0.381 |
|
| 1980 |
Henderson EE, Ribecky R. Transformation of Human Leukocytes With Epstein-Barr Virus After Cellular Exposure to Chemical or Physical Mutagens Journal of the National Cancer Institute. 64: 33-39. DOI: 10.1093/Jnci/64.1.33 |
0.342 |
|
| 1979 |
Henderson EE, Long WK, Ribecky R. Effects of nucleoside analogs on Epstein-Barr virus-induced transformation of human umbilical cord leukocytes and Epstein-Barr virus expression in transformed cells Antimicrobial Agents and Chemotherapy. 15: 101-110. PMID 218497 DOI: 10.1128/Aac.15.1.101 |
0.389 |
|
| Show low-probability matches. |